VESPER-JW: once-weekly berobenatide in Japan

This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.

Registry numberNCT07794761
StatusRecruiting
PhasePhase 3
SponsorPfizer
Enrollment180 participants
DesignNot stated
ConditionsObesity
InterventionsBerobenatide; Placebo
StartOct 2, 2026
Primary completionMar 14, 2029
Study completionNot stated
Results postedNot yet
Registry last updatedNot stated

Source: ClinicalTrials.gov (U.S. National Library of Medicine). See the trial changes feed for what has changed recently.

Share thisFacebookXEmail